● Recruiting

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Condition: Pancreatic Cancer · Sponsor: Medical College of Wisconsin

PhasePhase 2

Planned participants84

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Medical College of Wisconsin Cancer Center Clinical Trials Office · 866-680-0505 · cccto@mcw.edu

Always discuss trial participation with your own doctor first.

Locations (2)

HonorHealth Medical Group	Scottsdale, Arizona, United States	Recruiting
Froedtert & the Medical College of Wisconsin	Milwaukee, Wisconsin, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04683315